拉库纳中风早期神经系统恶化的救援疗法
Soo-Hyun Park1, Jonguk Kim2, Cindy W Yoon2
1Department of Neurology, SoonChunHyang University Hospital Seoul, Seoul, Republic of Korea.
BMC neurology
|September 7, 2024
概括
药物诱导高血压 (PIH) 比抗凝药更有效,用于治疗关性中风患者早期的神经系统恶化. PIH显示出更好的康复率和结果,具有相似的安全性.
科学领域:
- 神经学 神经学
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 早期神经系统恶化 (END) 是急性缺血性中风的常见并发症.
- 药理学诱导的高血压 (PIH) 和抗凝剂用于END治疗的有效性和安全性尚未得到充分证实.
- 经历END的性中风患者需要有效的救援疗法.
研究的目的:
- 为了比较PIH与抗凝剂的疗效和安全性,作为拉库纳中风中END进展的救援疗法.
- 确定哪种治疗策略会导致更好的神经恢复和功能结果.
- 评估两种治疗方法的安全性,包括出血转化和死亡率.
主要方法:
- 一项研究包括147名脑中风患者,在症状出现后3天内接受治疗.
- 患者接受了PIH的静脉注射烯或持续静脉注射阿格拉特罗班的抗凝药.
- 评估结果包括END恢复 (NIHSS改进),优异的功能结果 (3个月的mRS) 和安全事件.
主要成果:
- 与抗凝血剂组 (n=68) 相比,PIH组 (n=79) 的康复率显著更高 (77.2%) (51.5%,P<0.01).
- 在PIH组 (34.2%) 与抗凝血组 (16.2%,P=0.04) 相比,3个月的优异结果更频繁.
- PIH与END恢复独立相关 (调整HR3.91;P=0.02),安全结果没有显著差异.
结论:
- 药物诱导的高血压使用乙烯是一种更有效的救援疗法,用于进展早期的神经系统恶化在lacunar中风患者.
- 在这个患者队列中,阿斯巴特罗班抗凝剂的疗效较低.
- 无论是PIH还是抗凝药,都表现出与出血转化和死亡率相似的安全性.
相关概念视频
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...